Tag Archives: 2014

BRIC Opportunities 2014

While the tide has been turning for pharma in the BRIC markets, they will continue to be important but only if the industry has learnt the hard lessons of the last few years. Speaking to Pharm Exec for the 2014 Industry Outlook, Reenita Das, Partner at Frost & Sullivan, says its now more important than […]
Posted in Global, Strategy | Also tagged , , , , , , , | Leave a comment

Engage, But Gently: More Top Line Thoughts on 2014

More Top Line Thoughts on 2014:  Engage, but Gently Two weeks in and the New Year already seems old.  Yet members of our Pharm Exec Editorial Advisory Board are still eager to share their top of line predictions on trends that will shape the industry’s business and reputational assets – forward and backward – over […]
Posted in Op-Ed, Strategy | Also tagged , , , , , , | Leave a comment

Prove It! Top Line Thoughts on Trends That Will Shape the Industry in 2014

Top Line Thoughts on 2014:  Prove It! Ten days in and the New Year already seems old.  Yet members of our Pharm Exec Editorial Advisory Board are still eager to share their top of line predictions on trends that will shape the industry’s business and reputational assets – forward and backward – over the busy […]
Posted in Biotech, Strategy | Also tagged , , , | Leave a comment
  • Categories

  • Meta